A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection

Published:2016-03-23 Issue:8 Volume:36 Page:1101-1107
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Kao Jia‐Horng¹,Chien Rong‐Nan²,Chang Ting‐Tsung³,Peng Cheng‐Yuan⁴,Hu Tsung‐Hui⁵,Lo Gin‐Ho⁶,Wang Horng‐Yuan⁷,Chen Jyh‐Jou⁸,Yang Jenny C.⁹,Knox Steven J.⁹,Han Lingling⁹,Mo Hongmei⁹,Mathias Anita⁹,Brainard Diana M.⁹,Sheen I‐Shyan¹⁰,Hsu Yu‐Chun¹¹,Chu Chi‐Jen¹²¹³,Chuang Wan‐Long¹⁴

Affiliation:

1. National Taiwan University College of Medicine and Hospital Taipei Taiwan

2. Liver Research Unit Chang Gung Memorial Hospital‐Keelung Keelung Taiwan

3. Department of Internal Medicine National Cheng Kung University Hospital Tainan Taiwan

4. Department of Internal Medicine School of Medicine China Medical University Taichung Taiwan

5. Chang Gung Medical Foundation Kaohsiung Taiwan

6. Department of Medicine E‐Da Hospital Kaohsiung Taiwan

7. Department of Internal Medicine Mackay Memorial Hospital Taipei Taiwan

8. Department of Internal Medicine Chi Mei Hospital Liouying Tainan Taiwan

9. Gilead Sciences, Inc. Foster City CA USA

10. Chang Gung Memorial Hospital and Medical College Chang Gung University Taoyuan Taiwan

11. Department of Gastroenterology Changhua Christian Hospital Changhua Taiwan

12. Department of Medicine Taipei Veterans General Hospital Taipei Taiwan

13. School of Medicine National Yang‐Ming University Taipei Taiwan

14. Kaohsiung Medical University Hospital Kaohsiung Medical University Kaohsiung Taiwan

Funder

Gilead Sciences

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.13082

Reference26 articles.

1. Estimating the Incidence and Prevalence of Chronic Hepatitis C Infection in Taiwan Using Back Projection

2. Hepatitis C Virus Seromarkers and Subsequent Risk of Hepatocellular Carcinoma: Long-Term Predictors From a Community-Based Cohort Study

3. Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study

4. Changing prevalence of hepatitis C virus genotypes: Molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan

5. APASL consensus statements and management algorithms for hepatitis C virus infection

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients;The Eurasian Journal of Medicine;2022-06-03

2. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis;Journal of Viral Hepatitis;2022-04-06

3. The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2;The Korean Journal of Internal Medicine;2021-05-01

4. Real-world Effectiveness and Safety of Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C Genotype 2 Infection: Korean Multicenter Study;Journal of Korean Medical Science;2021

5. Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials;Hepatology Research;2020-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3